Malaysia's E-cigarette Legalization Still in Question

Aug.09.2022
Malaysia's E-cigarette Legalization Still in Question
The legalization of e-cigarettes sales in Malaysia faces challenges as the proposed "Generation End" anti-smoking bill is under review.

The main advocacy organization in the region, MOVE (Malaysia Vape Entity), has stated that the legalization of electronic cigarette sales in Malaysia still faces challenges, following unexpected turns prior to the Parliamentary elections.


Samsul Kamal Ariffin, the CEO of MOVE, has announced that the proposed "end intergenerational smoking" bill has been referred to a special committee in parliament for further scrutiny, which he considers to be positive news.


We are concerned that electronic cigarettes will be included in this anti-smoking bill, which will result in strict regulations and criminalization of consumers and retailers. Members of the specialized committee now have the opportunity to remove electronic cigarettes and non-combustible products from the legislation and treat them as tools for harm reduction in a completely different manner," said Mr. Alifin.


The date for Malaysia's general election is yet to be confirmed. However, if the next parliamentary session is held earlier, a select committee will take action to prepare a statement on its proposed amendments. MOVE will have a representative serving as a member of this special committee.


Similar to current legislation in New Zealand, Malaysia's proposed "intergenerational end" bill seeks to ban the sale of cigarettes and tobacco products to anyone born after 2007. However, unlike New Zealand, Malaysia's Health Minister also suggests adding electronic cigarette products to the intergenerational ban.


If Malaysia aims to reduce its overall smoking rate to below 5% by 2040, a ban on electronic cigarettes would not be able to achieve that goal. New Zealand has a smoking rate that is less than half of ours because they have become increasingly strict on smoking while only regulating the retail channels of adult e-cigarette products. New Zealand will likely achieve a smoke-free status at least a generation earlier than us because their approach to smoking and e-cigarette use is vastly different. If we want to save lives, Malaysia must do the same," he said.


In April, advocates for tobacco harm reduction (THR) were encouraged when regulations for electronic cigarette devices were announced to take effect on August 3rd. They had been lobbying for this to happen before the legalization of electronic cigarette sales, as have other THR supporters for many years.


We were concerned when the Health Minister proposed the "legacy of generations" bill on August 2nd and intended to pass it before parliament adjourned. Fortunately, enough members of parliament fought back, and the select committee or the next parliament can now regulate e-cigarettes through separate legislation. This is what needs to happen, and I believe it will.


As evidenced by 70 countries, the THR method is effective. Banning e-cigarettes will only harm smokers. Regulating e-cigarettes will provide a viable and less harmful alternative for smokers, not to mention much-needed tax revenue for Malaysia," said Mr. Alifin.


For the past decade, it has been a black market for electronic cigarette users in Malaysia, with unapproved products being untaxed and no safety guarantees for local consumers regarding product standards.


According to Mr. Alifin, providing a feasible, safe, and legal way for the 21% of Malaysians who smoke to improve their health and well-being is crucial. Electronic cigarettes are believed to be 95% less harmful than combustible tobacco. Making safer nicotine products legally available is the only way to significantly reduce Malaysia's unnecessary high smoking rates and save tens of thousands of lives each year.


The Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) has endorsed the legalization and regulation of e-cigarette sales in Malaysia, believing it will lead to a significant reduction in smoking rates.


MOVE continues to work with political figures and health officials in Malaysia to provide them with necessary information and support to effectively tackle the country's smoking epidemic. CAPHRA believes that the unsuccessful ban on e-cigarettes in Malaysia will be lifted in the next few months and there will be no turning back, said Nancy Lucas, CAPHRA's Executive Coordinator.


Statement:


This article is compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the views of 2FIRSTS. 2FIRSTS also cannot confirm the truthfulness or accuracy of the content of the article. The compilation of this article is solely for industry exchange and research purposes.


Due to limitations in translation proficiency, the translated article may not fully capture the original author's intended meaning. Therefore, please refer to the original text for accuracy.


2FIRSTS aligns completely with the stance and position of the Chinese government on any domestic, cross-strait, or foreign related issues.


The compilation of information is owned by the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Reuters Reveals California Raid on Illegal Vape Factory Involving Geek Bar and Foger, Days After WSJ Reported Importer's $1 Billion Factory Plan and White House Lobbying to Release Detained Vape Imports
Reuters Reveals California Raid on Illegal Vape Factory Involving Geek Bar and Foger, Days After WSJ Reported Importer's $1 Billion Factory Plan and White House Lobbying to Release Detained Vape Imports
US authorities raided a suspected illegal vape manufacturing facility in Chino, California, on October 30, 2026, discovering production and packaging machinery, unfinished vaping devices and approximately 850,000 vape-related items associated with brands including Geek Bar and Foger, Reuters reported on November 17. A person involved in the investigation said the raid provided concrete evidence of some manufacturing activities involving major Chinese vape labels taking place in the United States. Four days earlier, The Wall Street Journal reported that Hillfield, a US importer of Geek Bar products, had enlisted politically connected advisers to seek the release of detained vape shipments while presenting a $1 billion US manufacturing plan to the White House. No connection between the proposed investment and the raided facility has been established.
Enforcement
Nov.17
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08